China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'ProA study: ProActive Management Model in Metastatic Hormonesensitive Prostate Cancer (mHSPC) treated by Apalutamide'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135804
Registration Time: 2026/11/02
Type: Interventional study
Primary Sponsor: Sun Yat-sen University Cancer Center
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=258398
Published by HT Digital Content Services with permission from Health Daily Digest....